A Study of Teclistamab in Participants With Relapsed or Refractory Multiple Myeloma
A Study of Teclistamab in Participants With Relapsed or Refractory Multiple Myeloma
Active, not recruiting · NCT04557098 · Registry updated 2026-07-31Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| A Study of Teclistamab in Participants With Relapsed or Refractory Multiple Myeloma | Hemic and Lymphatic Diseases, Neoplasms by Site, hematologic disorder, hematopoietic and lymphoid system neoplasm, neoplasm | Active, not recruiting | Phase 2 | 2026-07-31 | NCT04557098 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Janssen Research & Development, LLC | 188 |
51 results · Page 1 of 3
Research sites
Swipe the table sideways for more columns.